Montefiore Medical Center

Montefiore Medical Center was paid $961.14M by Medicaid between Jan 2018 and Dec 2024, across 1445 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 9.5% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#1 of 231

Median peer was paid$561K

This provider vs. median1,713×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	606,561	$24.12M
2019	1,659,479	$74.51M
2020	2,569,875	$135.89M
2021	3,132,626	$150.90M
2022	3,038,053	$211.29M
2023	3,379,216	$217.88M
2024incomplete	2,726,526	$146.56M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	9.5%	574,884	509,794	$91.39M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	7.2%	413,654	367,386	$69.10M
G2067	Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)	4.9%	235,703	90,809	$47.31M
H0020	Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)	3.3%	870,230	109,766	$31.32M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.0%	145,168	138,414	$29.17M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	2.8%	213,317	150,860	$26.89M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.8%	135,654	129,145	$26.44M
99281	Emergency department visit for the evaluation and management, self-limited or minor	2.7%	124,499	118,120	$25.47M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.6%	166,900	142,747	$25.36M
99201		2.2%	301,067	281,198	$20.95M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	1.8%	91,035	83,839	$17.03M
J9271	Injection, pembrolizumab, 1 mg	1.7%	1,952	1,568	$16.53M

1433 more codes

G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	1.5%	119,555	$14.72M
99284	Emergency room visit (serious)	1.4%	73,057	$13.87M
96361	Intravenous infusion, hydration; each additional hour	1.2%	68,498	$11.68M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.2%	6,757	$11.24M
90834	Psychotherapy session, about 45 minutes	1.2%	63,466	$11.20M
80053	Comprehensive metabolic panel	1.1%	504,368	$10.88M
99285	Emergency room visit (most serious)	1.1%	58,301	$10.72M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	1.1%	165,926	$10.67M
G0397	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes	<1%	58,520	$9.61M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	129,355	$9.25M
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	79,343	$5.64M
86850		<1%	137,379	$5.15M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	40,108	$4.87M
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	1,040	$4.80M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	33,321	$4.69M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	39,169	$4.62M
92551		<1%	55,367	$4.59M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	25,490	$4.51M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	2,083	$4.51M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	68,425	$4.18M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	28,434	$4.16M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	107,030	$4.16M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,274	$3.88M
90791	Psychiatric diagnostic evaluation	<1%	17,452	$3.87M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	2,321	$3.74M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	24,779	$3.53M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	39,410	$3.44M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	805	$3.40M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	28,430	$3.38M
80048	Basic metabolic panel (calcium, ionized)	<1%	174,264	$3.22M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	4,645	$3.19M
70450	Computed tomography, head or brain; without contrast material	<1%	22,281	$3.18M
87631		<1%	43,160	$3.10M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	130,339	$3.09M
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	27,022	$3.07M
96415		<1%	9,285	$3.06M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	121,820	$3.03M
19318		<1%	1,170	$3.00M
86480		<1%	48,058	$2.99M
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	8,941	$2.96M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	26,696	$2.91M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	26,201	$2.91M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	23,664	$2.90M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,806	$2.79M
76770		<1%	19,528	$2.77M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,863	$2.73M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	164,640	$2.68M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	43,243	$2.65M
93458		<1%	1,792	$2.64M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	19,674	$2.64M
80061	Lipid panel	<1%	243,061	$2.62M
93970		<1%	12,364	$2.62M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	1,591	$2.58M
J2505	Injection, pegfilgrastim, 6 mg	<1%	773	$2.56M
H0005	Alcohol and/or drug services; group counseling by a clinician	<1%	26,936	$2.39M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	46,303	$2.36M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	5,490	$2.27M
77386		<1%	8,833	$2.27M
87536		<1%	26,227	$2.23M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	2,534	$2.18M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,387	$2.17M
54161		<1%	1,661	$2.09M
90836		<1%	19,233	$2.09M
99203	Doctor's office visit, new patient (routine)	<1%	12,295	$2.07M
77412		<1%	7,190	$2.03M
86901		<1%	135,557	$1.89M
99204	Doctor's office visit, new patient (more involved)	<1%	9,888	$1.86M
90847	Family psychotherapy with the patient present, 50 minutes	<1%	7,138	$1.83M
90792	Psychiatric diagnostic evaluation with medical services	<1%	7,820	$1.82M
87507		<1%	6,472	$1.77M
90686		<1%	85,187	$1.75M
36415	Collection of venous blood by venipuncture	<1%	151,527	$1.74M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	77,958	$1.72M
52000		<1%	1,642	$1.71M
J0897	Injection, denosumab, 1 mg	<1%	1,357	$1.71M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	5,642	$1.68M
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	13,708	$1.67M
20610		<1%	6,310	$1.65M
T1999	Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"	<1%	681	$1.63M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	6,842	$1.63M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	42,839	$1.63M
59025	Fetal non-stress test	<1%	12,356	$1.62M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	2,680	$1.61M
96375	Therapeutic injection; each additional sequential IV push	<1%	68,617	$1.60M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	5,903	$1.55M
64483		<1%	1,766	$1.50M
51798		<1%	5,954	$1.50M
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	27,874	$1.49M
86900		<1%	135,605	$1.48M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	80,695	$1.48M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	5,684	$1.46M
36512		<1%	1,398	$1.45M
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	2,175	$1.45M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	642,069	$1.43M
99401		<1%	23,111	$1.42M
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	14,411	$1.40M
81513		<1%	22,153	$1.39M
J9299	Injection, nivolumab, 1 mg	<1%	264	$1.39M
D0120	Dental checkup, returning patient	<1%	30,745	$1.34M
77336		<1%	5,515	$1.34M
J9306	Injection, pertuzumab, 1 mg	<1%	235	$1.30M
93976		<1%	6,303	$1.29M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	69,766	$1.28M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	10,087	$1.27M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	8,882	$1.27M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	8,747	$1.26M
41899	Unlisted procedure, dentoalveolar structures	<1%	798	$1.26M
19083		<1%	898	$1.25M
99244	Office or other outpatient consultation, moderate to high complexity	<1%	6,118	$1.25M
83036	Hemoglobin; glycosylated (A1C)	<1%	261,197	$1.24M
76818		<1%	15,311	$1.22M
H0004	Behavioral health counseling and therapy, per 15 minutes	<1%	17,591	$1.20M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	6,445	$1.19M
Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	<1%	910	$1.17M
J3490	Unclassified drugs	<1%	34,579	$1.17M
87481		<1%	24,219	$1.16M
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	37,510	$1.10M
92567		<1%	19,089	$1.09M
99381		<1%	7,598	$1.09M
D0150	Comprehensive oral evaluation - new or established patient	<1%	17,555	$1.07M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	13,172	$1.07M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,598	$1.04M
87806		<1%	56,645	$1.04M
92557		<1%	11,963	$1.03M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	5,907	$1.03M
47562		<1%	577	$1.02M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	8,631	$1.01M
80076		<1%	60,710	$1.00M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,845	$1.00M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	68,506	$993K
86359		<1%	24,587	$986K
90651		<1%	17,402	$982K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,828	$978K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	10,882	$976K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	917	$973K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	608	$968K
74183		<1%	3,531	$963K
64493		<1%	1,224	$953K
99385		<1%	8,255	$941K
86780		<1%	116,326	$927K
90670		<1%	29,200	$925K
J9312	Injection, rituximab, 10 mg	<1%	268	$910K
88142		<1%	39,983	$892K
J9035	Injection, bevacizumab, 10 mg	<1%	206	$878K
71250		<1%	11,311	$875K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,625	$867K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	5,521	$844K
86360		<1%	24,310	$841K
90837	Psychotherapy session, about an hour	<1%	4,511	$831K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	62,789	$826K
H2010	Comprehensive medication services, per 15 minutes	<1%	8,517	$824K
81243		<1%	8,849	$816K
12001		<1%	2,770	$808K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	495	$800K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	6,893	$799K
84443	Thyroid stimulating hormone (TSH)	<1%	158,159	$797K
76830	Ultrasound, transvaginal	<1%	14,423	$790K
88342		<1%	10,801	$784K
95782		<1%	973	$778K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	169	$771K
67028	Intravitreal injection of a pharmacologic agent	<1%	6,342	$771K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	3,441	$755K
31237		<1%	517	$751K
99243		<1%	3,924	$751K
J9145	Injection, daratumumab, 10 mg	<1%	243	$750K
36430		<1%	6,074	$749K
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,894	$749K
90750		<1%	6,399	$746K
82728		<1%	84,343	$741K
46607		<1%	1,016	$722K
86803		<1%	84,244	$722K
96127		<1%	142,051	$718K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	9,480	$713K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	1,299	$710K
90671		<1%	4,689	$703K
83655		<1%	54,886	$702K
80050	General health panel	<1%	32,605	$691K
71046	Radiologic examination, chest; 2 views	<1%	88,360	$690K
81001		<1%	188,523	$687K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	80,221	$685K
V2632	Posterior chamber intraocular lens	<1%	13,271	$684K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	15,835	$681K
12011		<1%	2,364	$678K
43235		<1%	815	$676K
99442		<1%	6,647	$660K
92134		<1%	8,157	$657K
86769		<1%	19,216	$656K
95117		<1%	9,803	$653K
31231		<1%	5,704	$652K
82607		<1%	70,062	$652K
83970		<1%	19,779	$648K
J9041	Injection, bortezomib, 0.1 mg	<1%	1,139	$644K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	12,781	$639K
62323		<1%	951	$634K
77334		<1%	3,064	$631K
10060		<1%	2,837	$628K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	16,763	$612K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	597	$607K
90715		<1%	26,666	$605K
77066	Tomosynthesis, mammo	<1%	6,564	$602K
99386		<1%	5,191	$599K
83520		<1%	6,246	$599K
84439		<1%	103,710	$597K
73221		<1%	2,892	$591K
81329		<1%	7,722	$584K
88307		<1%	3,168	$583K
D1351	Sealant - per tooth	<1%	14,034	$580K
72141		<1%	3,156	$572K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	602	$572K
20611		<1%	596	$568K
76536		<1%	9,518	$567K
86003		<1%	12,345	$556K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	20,073	$552K
83880		<1%	29,316	$547K
G2078	Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure	<1%	16,764	$545K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	12,477	$542K
99205	Prolong outpt/office vis	<1%	2,646	$528K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	18,118	$523K
97162		<1%	4,089	$516K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	326	$513K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	9,337	$504K
72197		<1%	1,483	$504K
H0001	Alcohol and/or drug assessment	<1%	2,457	$502K
29881		<1%	646	$496K
99443		<1%	4,620	$496K
77300		<1%	1,794	$490K
87799		<1%	9,872	$487K
93320		<1%	7,697	$486K
Q5120	Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg	<1%	204	$485K
92083		<1%	6,563	$476K
J2357	Injection, omalizumab, 5 mg	<1%	2,676	$475K
86832		<1%	2,284	$469K
77290		<1%	1,466	$469K
74178		<1%	2,897	$467K
77065	Tomosynthesis, mammo	<1%	7,439	$463K
76642		<1%	10,724	$461K
83021		<1%	25,758	$457K
84466		<1%	60,239	$456K
96367		<1%	6,763	$448K
81025		<1%	20,974	$446K
86833		<1%	2,281	$446K
31575		<1%	4,101	$445K
77063	Screening digital breast tomosynthesis, bilateral	<1%	16,897	$438K
11900		<1%	1,478	$437K
H0049	Alcohol and/or drug screening	<1%	14,992	$436K
D1120	Dental cleaning, child	<1%	9,898	$434K
99383		<1%	3,378	$428K
75574		<1%	2,681	$416K
0002A		<1%	10,945	$412K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,362	$412K
87086	Culture, bacterial; quantitative colony count, urine	<1%	135,804	$411K
99441		<1%	4,432	$411K
93325		<1%	9,449	$407K
77301		<1%	680	$405K
87497		<1%	12,301	$403K
90739		<1%	3,132	$401K
90732		<1%	3,920	$397K
0001A		<1%	12,320	$395K
30140		<1%	224	$390K
87490		<1%	51,519	$387K
C1769	Guide wire	<1%	6,321	$385K
95250		<1%	1,825	$385K
88185		<1%	2,916	$383K
93925		<1%	2,138	$382K
82803		<1%	14,904	$381K
J0791	Injection, crizanlizumab-tmca, 5 mg	<1%	125	$378K
64615		<1%	980	$378K
29827		<1%	188	$378K
85610		<1%	130,595	$374K
96401		<1%	5,241	$373K
70491		<1%	2,715	$371K
84403		<1%	16,637	$361K
70486		<1%	4,242	$360K
87340		<1%	69,683	$357K
76825		<1%	1,810	$357K
58558		<1%	282	$352K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	8,935	$351K
T2022	Case management, per month	<1%	4,216	$350K
D1110	Prophylaxis - adult	<1%	7,828	$348K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,307	$347K
29876		<1%	254	$343K
0223U		<1%	2,801	$339K
86762		<1%	28,293	$338K
12002		<1%	1,115	$337K
J1453	Injection, fosaprepitant, 1 mg	<1%	4,129	$337K
82784		<1%	25,134	$337K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	828	$330K
52356		<1%	228	$327K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	831	$324K
91322		<1%	4,057	$320K
87563		<1%	13,751	$320K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,621	$316K
C1889	Implantable/insertable device, not otherwise classified	<1%	2,196	$316K
97010		<1%	19,886	$315K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,851	$313K
99384		<1%	2,565	$312K
70544		<1%	1,866	$310K
87522	Neg quan hep c or qual rna	<1%	8,022	$307K
92133		<1%	4,346	$306K
86765		<1%	28,795	$306K
87486		<1%	5,735	$304K
86923		<1%	5,603	$304K
29888		<1%	118	$302K
94060		<1%	4,930	$302K
84702		<1%	83,188	$296K
86706		<1%	39,855	$295K
77338		<1%	1,155	$293K
J9070	Cyclophosphamide, 100 mg	<1%	1,008	$291K
97803		<1%	5,340	$290K
20550		<1%	1,113	$289K
11721		<1%	4,177	$288K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	2,660	$286K
77280		<1%	994	$286K
88341		<1%	4,192	$283K
99402		<1%	4,285	$282K
82746		<1%	32,110	$280K
86317		<1%	1,007	$275K
83735		<1%	138,273	$273K
90734		<1%	14,297	$272K
97802		<1%	4,344	$270K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	7,982	$269K
81337		<1%	6,114	$268K
80321		<1%	9,166	$266K
95816		<1%	1,108	$265K
94726		<1%	7,239	$263K
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	<1%	262	$262K
77062		<1%	3,403	$262K
99382		<1%	1,928	$261K
77385		<1%	1,164	$260K
92526		<1%	1,920	$259K
94010		<1%	7,977	$259K
96417		<1%	5,380	$258K
83540		<1%	79,768	$257K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	99,492	$256K
96156		<1%	1,385	$256K
76641		<1%	4,082	$255K
26055		<1%	236	$254K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	75,157	$253K
82570		<1%	75,733	$252K
93971		<1%	3,516	$252K
76801		<1%	3,356	$250K
84402		<1%	11,519	$248K
96409		<1%	2,906	$245K
92579		<1%	4,281	$242K
90633		<1%	16,277	$241K
92555		<1%	3,211	$238K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,607	$238K
81229		<1%	269	$237K
93880		<1%	1,589	$233K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	6,676	$232K
87517		<1%	5,205	$232K
84207		<1%	9,127	$230K
90680		<1%	18,414	$222K
94729		<1%	7,641	$217K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	5,763	$216K
84153		<1%	21,134	$215K
92587		<1%	4,176	$213K
76882		<1%	4,046	$212K
11901		<1%	695	$209K
C1781	Mesh (implantable)	<1%	1,138	$207K
88304		<1%	5,550	$206K
73562		<1%	11,562	$205K
A9585	Injection, gadobutrol, 0.1 ml	<1%	17,096	$205K
J3535	Drug administered through a metered dose inhaler	<1%	8,382	$204K
87902		<1%	738	$204K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,094	$203K
51741		<1%	1,234	$203K
81003		<1%	76,217	$200K
93923		<1%	2,852	$199K
83001		<1%	12,728	$197K
95024		<1%	926	$196K
81401		<1%	1,189	$196K
49650		<1%	100	$196K
77080		<1%	5,101	$195K
84146		<1%	11,657	$195K
76942		<1%	1,497	$195K
46600		<1%	1,003	$193K
87081		<1%	43,014	$192K
72110		<1%	6,429	$192K
70543		<1%	539	$186K
55700		<1%	162	$186K
90707		<1%	8,186	$186K
92610		<1%	1,514	$184K
80197		<1%	26,018	$183K
77061		<1%	2,917	$183K
93017		<1%	3,869	$182K
D0274	Bitewings - four radiographic images	<1%	7,936	$181K
88112		<1%	2,951	$181K
96416		<1%	729	$181K
82043		<1%	49,137	$180K
73700		<1%	1,523	$179K
76870		<1%	4,602	$176K
90697		<1%	9,325	$175K
58661		<1%	134	$175K
84445		<1%	2,474	$174K
86787		<1%	25,711	$174K
85730		<1%	101,037	$172K
99173		<1%	6,484	$172K
96411		<1%	3,186	$171K
72195		<1%	921	$169K
76857		<1%	14,604	$169K
73630		<1%	15,004	$168K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	236	$168K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	2,698	$166K
86161		<1%	10,969	$166K
96402		<1%	2,705	$164K
83516		<1%	11,211	$163K
99188		<1%	3,033	$163K
88360		<1%	1,806	$162K
93975		<1%	862	$161K
86704		<1%	21,622	$160K
20680		<1%	100	$159K
84100		<1%	90,318	$158K
71271		<1%	2,233	$157K
C1760	Closure device, vascular (implantable/insertable)	<1%	1,227	$157K
69210		<1%	3,895	$156K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,315	$156K
73030		<1%	12,499	$155K
87077		<1%	35,507	$155K
74240		<1%	1,906	$155K
90999	Dialysis (unlisted procedure)	<1%	688	$155K
97165		<1%	1,391	$154K
93351		<1%	1,296	$153K
58100		<1%	478	$153K
86902		<1%	1,037	$152K
87088		<1%	34,593	$151K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	44,857	$150K
72100		<1%	11,660	$150K
78582		<1%	369	$148K
86922		<1%	2,677	$147K
84255		<1%	6,722	$147K
77295		<1%	631	$144K
99245		<1%	673	$143K
99406		<1%	3,518	$143K
83002		<1%	9,953	$143K
41010		<1%	132	$142K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,316	$141K
90656		<1%	10,951	$138K
G2068	Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)	<1%	531	$137K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	2,865	$136K
82670		<1%	5,766	$136K
72156		<1%	535	$135K
97804		<1%	2,578	$135K
87653		<1%	4,189	$134K
84425		<1%	10,539	$134K
31579		<1%	437	$134K
57454		<1%	355	$134K
90619		<1%	1,351	$134K
72082		<1%	3,314	$133K
73130		<1%	11,801	$133K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	86	$133K
97163		<1%	936	$132K
90716		<1%	7,331	$132K
86235		<1%	7,509	$131K
29125		<1%	861	$131K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	5,257	$131K
72146		<1%	830	$130K
81479	Unlisted molecular pathology procedure	<1%	854	$129K
42830		<1%	81	$129K
90698		<1%	9,621	$128K
86140		<1%	49,292	$127K
87529		<1%	3,320	$127K
93225		<1%	1,653	$126K
74174		<1%	865	$126K
72131		<1%	1,656	$126K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	<1%	75	$125K
86735		<1%	16,995	$124K
52310		<1%	113	$124K
93886		<1%	410	$123K
64400		<1%	333	$122K
73610		<1%	12,137	$122K
83615		<1%	38,957	$122K
D1330		<1%	6,599	$120K
90849		<1%	1,203	$120K
72158		<1%	452	$120K
84446		<1%	10,014	$120K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,855	$119K
73560		<1%	9,726	$118K
90710		<1%	8,841	$118K
51702		<1%	550	$117K
83605		<1%	80,134	$117K
82330		<1%	80,852	$117K
C1776	Joint device (implantable)	<1%	26	$116K
74160		<1%	1,071	$115K
95913		<1%	987	$114K
82948		<1%	53,630	$114K
96112		<1%	851	$114K
0003A		<1%	3,061	$113K
86021		<1%	5,595	$113K
73200		<1%	1,026	$113K
92552		<1%	1,182	$111K
90746		<1%	2,676	$111K
84597		<1%	9,239	$111K
76775		<1%	3,641	$110K
D1208	Topical application of fluoride, excluding varnish	<1%	7,251	$109K
90381		<1%	313	$108K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	554	$108K
76827		<1%	1,814	$108K
83883		<1%	5,100	$107K
73110		<1%	8,799	$107K
87070		<1%	20,328	$106K
90472	Immunization administration, each additional vaccine (list separately)	<1%	21,865	$106K
29848		<1%	53	$105K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	243	$104K
90648		<1%	7,120	$104K
99397		<1%	950	$104K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	11,546	$103K
82785		<1%	10,114	$102K
84590		<1%	10,182	$101K
75561		<1%	336	$101K
97161		<1%	960	$101K
90696		<1%	7,386	$99K
87581		<1%	5,784	$99K
83690		<1%	85,298	$98K
0124A		<1%	2,767	$97K
82525		<1%	9,992	$96K
76813		<1%	1,367	$96K
90662		<1%	3,074	$95K
82627		<1%	5,428	$95K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	110	$94K
93505		<1%	60	$93K
99407		<1%	1,893	$93K
92136		<1%	936	$93K
86708		<1%	10,403	$93K
86355		<1%	2,278	$90K
58301		<1%	655	$89K
10005		<1%	492	$89K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	577	$89K
84703		<1%	30,962	$88K
86200		<1%	5,579	$88K
D0220	Intraoral - periapical first radiographic image	<1%	8,439	$88K
H0033	Oral medication administration, direct observation	<1%	2,453	$88K
99232	Hospital visit by a doctor, follow-up day	<1%	811	$87K
J1750	Injection, iron dextran, 50 mg	<1%	494	$86K
J2704	Injection, propofol, 10 mg	<1%	52,007	$86K
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	933	$85K
92235		<1%	442	$85K
49591		<1%	54	$85K
70547		<1%	566	$84K
82610		<1%	6,086	$84K
84156		<1%	34,371	$84K
86376		<1%	7,601	$82K
71045	Radiologic examination, chest; single view	<1%	18,737	$82K
90691		<1%	984	$82K
73502		<1%	6,230	$82K
82375		<1%	80,197	$82K
82550		<1%	79,261	$82K
76514		<1%	781	$81K
77085		<1%	732	$81K
H0038	Self-help/peer services, per 15 minutes	<1%	1,477	$81K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	2,831	$81K
0071A		<1%	2,344	$81K
72040		<1%	4,642	$81K
70496		<1%	757	$81K
90620		<1%	1,588	$81K
88108		<1%	2,085	$80K
58300		<1%	603	$78K
90723		<1%	5,087	$78K
84432		<1%	3,737	$77K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	26,346	$77K
87338		<1%	10,594	$76K
17110		<1%	232	$76K
88262		<1%	838	$75K
82397		<1%	3,823	$75K
84550		<1%	27,206	$74K
87186		<1%	24,141	$74K
96376		<1%	9,071	$73K
D0230	Intraoral - periapical each additional radiographic image	<1%	7,052	$71K
93226		<1%	1,222	$71K
86870		<1%	2,919	$71K
88184		<1%	2,586	$71K
87400		<1%	3,721	$71K
70498		<1%	478	$71K
19281		<1%	80	$70K
74230		<1%	1,168	$70K
81382		<1%	247	$70K
97022		<1%	2,239	$70K
11982		<1%	203	$70K
83498		<1%	3,228	$69K
84484		<1%	70,514	$68K
90480		<1%	2,147	$68K
70480		<1%	633	$68K
80069		<1%	8,716	$68K
90700		<1%	5,555	$67K
11981		<1%	223	$67K
84630		<1%	10,722	$67K
93246		<1%	1,140	$66K
82951		<1%	9,062	$66K
81206		<1%	571	$66K
82652		<1%	1,824	$66K
C1726	Catheter, balloon dilatation, non-vascular	<1%	489	$66K
93613		<1%	105	$65K
99459		<1%	2,598	$64K
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	2,467	$64K
86695		<1%	3,066	$64K
76886		<1%	909	$64K
V2788	Presbyopia correcting function of intraocular lens	<1%	872	$64K
72050		<1%	2,124	$64K
97166		<1%	516	$64K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	2,175	$64K
J7030	Infusion, normal saline solution , 1000 cc	<1%	74,725	$62K
85245		<1%	2,340	$62K
93242		<1%	637	$61K
83550		<1%	16,951	$61K
82378		<1%	4,716	$60K
95811		<1%	119	$60K
90378		<1%	166	$59K
29515		<1%	360	$58K
90744		<1%	3,921	$58K
86038		<1%	13,904	$58K
77373		<1%	81	$57K
87147		<1%	10,116	$57K
82157		<1%	2,501	$57K
92582		<1%	645	$57K
84154		<1%	5,134	$57K
64405		<1%	324	$57K
30520		<1%	83	$57K
73521		<1%	3,015	$56K
92020		<1%	617	$56K
97116		<1%	2,098	$56K
82565		<1%	22,874	$56K
93248		<1%	705	$55K
86682		<1%	3,899	$55K
A4648	Tissue marker, implantable, any type, each	<1%	492	$55K
82533		<1%	4,306	$55K
86696		<1%	4,804	$55K
88173		<1%	2,071	$55K
82105		<1%	9,260	$55K
74018		<1%	4,798	$54K
86592		<1%	9,533	$54K
11056		<1%	242	$54K
86335		<1%	2,151	$54K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	2,903	$54K
64635		<1%	82	$53K
85246		<1%	3,427	$53K
74221		<1%	1,073	$53K
A6410	Eye pad, sterile, each	<1%	1,652	$52K
D9239		<1%	476	$52K
82088		<1%	1,339	$52K
85652		<1%	40,828	$52K
J8501	Aprepitant, oral, 5 mg	<1%	3,274	$51K
0012A		<1%	1,432	$51K
93978		<1%	466	$51K
0072A		<1%	1,290	$51K
96160		<1%	1,168	$51K
J9045	Injection, carboplatin, 50 mg	<1%	1,896	$51K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	2,104	$51K
91200		<1%	2,350	$50K
51600		<1%	76	$50K
95885		<1%	987	$50K
86147		<1%	3,193	$49K
D1206	Topical application of fluoride varnish	<1%	1,640	$49K
96167		<1%	1,089	$49K
69200		<1%	845	$49K
72070		<1%	3,259	$49K
90717		<1%	382	$48K
86304		<1%	3,273	$48K
73564		<1%	1,911	$48K
86255		<1%	3,301	$48K
93798		<1%	1,183	$47K
99223	Prolong inpt eval add15 m	<1%	175	$47K
D0272	Bitewings - two radiographic images	<1%	3,433	$47K
86357		<1%	2,289	$47K
84480		<1%	9,772	$46K
87205		<1%	21,725	$46K
82180		<1%	5,459	$46K
94618		<1%	1,759	$45K
86334		<1%	3,346	$45K
88275		<1%	278	$45K
86800		<1%	4,453	$45K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	4,570	$45K
J9267	Injection, paclitaxel, 1 mg	<1%	2,545	$45K
73140		<1%	4,299	$44K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	9,158	$44K
73590		<1%	5,141	$44K
95886		<1%	653	$44K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	398	$44K
88300		<1%	2,690	$44K
84270		<1%	1,700	$44K
0011A		<1%	1,661	$43K
29826		<1%	139	$43K
C1753	Catheter, intravascular ultrasound	<1%	119	$43K
59841		<1%	50	$43K
82800		<1%	67,560	$43K
C1759	Catheter, intracardiac echocardiography	<1%	98	$43K
82977		<1%	13,547	$43K
86945		<1%	1,555	$43K
73522		<1%	1,400	$43K
86225		<1%	10,993	$42K
90678		<1%	249	$42K
81257		<1%	485	$42K
D1354		<1%	2,304	$41K
D0330	Panoramic radiographic image	<1%	1,394	$41K
83993		<1%	3,931	$40K
86812		<1%	898	$40K
98968		<1%	784	$40K
83921		<1%	2,944	$40K
86618		<1%	3,293	$39K
73080		<1%	4,579	$39K
54150		<1%	37	$39K
82542		<1%	2,433	$38K
90647		<1%	2,399	$37K
90375		<1%	12	$37K
J7050	Infusion, normal saline solution, 250 cc	<1%	64,643	$37K
82164		<1%	2,175	$37K
84244		<1%	1,545	$37K
86431		<1%	10,068	$37K
0742T		<1%	180	$37K
94760		<1%	6,774	$37K
88271		<1%	655	$36K
J1756	Injection, iron sucrose, 1 mg	<1%	1,182	$36K
72157		<1%	149	$36K
92082		<1%	266	$36K
82024		<1%	946	$36K
88312		<1%	1,757	$35K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	42,575	$35K
64721		<1%	43	$35K
88237		<1%	220	$35K
86880		<1%	2,624	$35K
82247		<1%	5,331	$35K
30420		<1%	12	$34K
92285		<1%	432	$34K
51728		<1%	88	$34K
84305		<1%	2,293	$34K
10061		<1%	174	$34K
92611		<1%	380	$34K
82947		<1%	91,530	$34K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	339	$34K
96900		<1%	1,167	$34K
73720		<1%	96	$34K
91321		<1%	838	$33K
92025		<1%	265	$33K
76981		<1%	470	$33K
97164		<1%	433	$33K
90675		<1%	320	$33K
C1874	Stent, coated/covered, with delivery system	<1%	28	$33K
J0178	Injection, aflibercept, 1 mg	<1%	34	$33K
92060		<1%	386	$33K
86141		<1%	4,488	$33K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	14,671	$32K
83050		<1%	80,127	$32K
88313		<1%	2,738	$32K
86008		<1%	1,623	$32K
86146		<1%	3,002	$32K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	635	$31K
0064A		<1%	984	$31K
77072		<1%	2,056	$31K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	575	$31K
D7140	Extraction, erupted tooth or exposed root	<1%	596	$31K
77073		<1%	1,390	$31K
90632		<1%	542	$31K
71270		<1%	174	$30K
82150		<1%	26,786	$30K
85046		<1%	20,995	$30K
92250		<1%	398	$30K
D9997		<1%	646	$30K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	764	$30K
D0210	Intraoral - complete series of radiographic images	<1%	3,615	$29K
83519		<1%	1,209	$29K
84144		<1%	1,569	$28K
76819	Fetal biophysical profile; without non-stress testing	<1%	505	$28K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	41,906	$28K
81207		<1%	232	$28K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	652	$28K
82672		<1%	1,536	$28K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	935	$28K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	217	$28K
84681		<1%	1,811	$28K
15830		<1%	13	$28K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	460	$28K
86665		<1%	2,289	$28K
85240		<1%	2,489	$27K
A4314	Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	<1%	2,100	$27K
0296T		<1%	471	$27K
J1741	Injection, ibuprofen, 100 mg	<1%	4,796	$27K
95912		<1%	214	$27K
36561		<1%	26	$27K
86849		<1%	2,753	$27K
84295		<1%	88,534	$27K
93244		<1%	391	$27K
73552		<1%	2,423	$27K
87040		<1%	9,277	$26K
95911		<1%	254	$26K
86777		<1%	1,647	$26K
J8540	Dexamethasone, oral, 0.25 mg	<1%	12,498	$26K
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	2,959	$26K
74019		<1%	5,314	$26K
90677		<1%	151	$25K
0134A		<1%	734	$25K
84155		<1%	11,252	$25K
J9171	Injection, docetaxel, 1 mg	<1%	268	$25K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	1,121	$24K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	48,369	$24K
C1764	Event recorder, cardiac (implantable)	<1%	91	$24K
98960		<1%	1,303	$24K
93280		<1%	374	$24K
D9310		<1%	509	$24K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	50	$24K
84520		<1%	18,428	$24K
86325		<1%	515	$23K
84436		<1%	6,698	$23K
96368		<1%	1,233	$23K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	174	$23K
86644		<1%	2,203	$23K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	37,717	$23K
86301		<1%	2,264	$23K
74455		<1%	71	$23K
90785		<1%	1,665	$23K
82085		<1%	1,791	$23K
C1758	Catheter, ureteral	<1%	1,322	$23K
28296		<1%	12	$23K
19081		<1%	12	$23K
92524		<1%	153	$23K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	625	$23K
72081		<1%	848	$23K
D0160		<1%	327	$22K
90380		<1%	95	$22K
83521		<1%	2,726	$22K
29130		<1%	147	$22K
83695		<1%	2,342	$21K
12013		<1%	76	$21K
J9206	Injection, irinotecan, 20 mg	<1%	1,096	$21K
84132		<1%	72,503	$21K
82310		<1%	13,446	$21K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	36,511	$21K
86593		<1%	3,873	$20K
62321		<1%	14	$20K
96450		<1%	37	$20K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	324	$20K
54640		<1%	15	$20K
J2997	Injection, alteplase recombinant, 1 mg	<1%	15	$20K
73090		<1%	3,466	$20K
51797		<1%	75	$20K
82657		<1%	866	$20K
72170		<1%	2,072	$19K
29879		<1%	29	$19K
49652		<1%	12	$19K
88230		<1%	390	$19K
96377		<1%	1,344	$19K
80164		<1%	2,922	$19K
A6402	Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	1,301	$19K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	4,510	$19K
81270		<1%	390	$18K
81596		<1%	510	$18K
64494		<1%	959	$18K
82950		<1%	4,074	$18K
71101		<1%	2,227	$18K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,826	$18K
85044		<1%	17,002	$18K
82248		<1%	5,262	$18K
70360		<1%	1,507	$18K
83010		<1%	2,102	$18K
64450		<1%	111	$18K
J0592	Injection, buprenorphine hydrochloride, 0.1 mg	<1%	1,217	$18K
20552		<1%	101	$18K
66982		<1%	12	$18K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,990	$18K
83090		<1%	1,393	$18K
85613		<1%	2,764	$17K
83525		<1%	1,863	$17K
J9370	Vincristine sulfate, 1 mg	<1%	1,914	$17K
93990		<1%	339	$17K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	6,319	$17K
93282		<1%	182	$17K
76098		<1%	94	$17K
17250		<1%	75	$17K
73060		<1%	2,147	$17K
87530		<1%	344	$16K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	688	$16K
86039		<1%	4,379	$16K
85247		<1%	1,208	$16K
96158		<1%	220	$16K
J9190	Injection, fluorouracil, 500 mg	<1%	1,190	$16K
J2680	Injection, fluphenazine decanoate, up to 25 mg	<1%	597	$16K
92556		<1%	321	$16K
97168		<1%	259	$16K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	844	$16K
J0690	Injection, cefazolin sodium, 500 mg	<1%	17,891	$15K
D0140	Limited oral evaluation - problem focused	<1%	1,412	$15K
78264		<1%	72	$15K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	524	$15K
52332		<1%	13	$15K
70490		<1%	89	$15K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	410	$15K
74246		<1%	220	$15K
85384		<1%	3,962	$15K
80349		<1%	2,141	$15K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	4,498	$15K
96116		<1%	170	$15K
51784		<1%	438	$15K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	388	$15K
82677		<1%	1,042	$15K
86162		<1%	1,217	$15K
73718		<1%	61	$14K
15853		<1%	760	$14K
11402		<1%	12	$14K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,445	$14K
36224		<1%	12	$14K
84481		<1%	2,641	$14K
J1270	Injection, doxercalciferol, 1 mcg	<1%	391	$14K
88346		<1%	273	$14K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	2,521	$14K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	5,606	$14K
77370		<1%	64	$14K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	521	$14K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	73	$14K
96113		<1%	131	$14K
94645		<1%	1,118	$14K
90681		<1%	1,045	$13K
90713		<1%	886	$13K
86341		<1%	993	$13K
82787		<1%	1,167	$13K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	6,024	$13K
93312		<1%	41	$13K
97760		<1%	172	$13K
85362		<1%	9,902	$13K
80180		<1%	1,702	$13K
29405		<1%	56	$13K
94664		<1%	1,494	$12K
82390		<1%	2,108	$12K
G0008	Administration of influenza virus vaccine	<1%	1,393	$12K
G2077	Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code	<1%	180	$12K
72052		<1%	357	$12K
87177		<1%	1,562	$12K
67228		<1%	29	$12K
85660		<1%	2,166	$12K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	12,561	$12K
96523		<1%	255	$12K
0154A		<1%	343	$12K
0051A		<1%	324	$12K
82668		<1%	1,056	$12K
98967		<1%	251	$12K
84134		<1%	1,902	$12K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	44,255	$12K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	103	$12K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	5,501	$11K
86645		<1%	1,950	$11K
89051		<1%	1,779	$11K
82270		<1%	2,914	$11K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,892	$11K
87634		<1%	2,804	$11K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	56,582	$11K
92523		<1%	53	$11K
27096		<1%	42	$11K
82465		<1%	3,922	$11K
95180		<1%	38	$11K
J0401	Injection, aripiprazole (abilify maintena), 1 mg	<1%	46	$11K
51705		<1%	53	$11K
83835		<1%	773	$11K
82374		<1%	10,663	$11K
85651		<1%	9,017	$10K
97597		<1%	55	$10K
96154		<1%	436	$10K
64644		<1%	31	$10K
82274		<1%	2,779	$10K
D9430		<1%	134	$10K
24640		<1%	29	$10K
85380		<1%	645	$10K
76377		<1%	187	$10K
72128		<1%	160	$10K
80323		<1%	2,100	$10K
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	<1%	161	$10K
87593		<1%	95	$10K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	8,582	$10K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	2,567	$9K
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	<1%	1,088	$9K
80178		<1%	1,817	$9K
70487		<1%	70	$9K
52287		<1%	12	$9K
93270		<1%	119	$9K
90685		<1%	549	$9K
95807		<1%	13	$9K
73000		<1%	721	$9K
20605		<1%	38	$9K
86709		<1%	1,151	$9K
93656		<1%	13	$9K
11102		<1%	14	$9K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	22,280	$9K
80354		<1%	201	$9K
87449		<1%	2,774	$8K
86403		<1%	1,831	$8K
D9110		<1%	586	$8K
82103		<1%	888	$8K
95018		<1%	46	$8K
78306		<1%	71	$8K
11104		<1%	13	$8K
86705		<1%	1,470	$8K
86774		<1%	589	$8K
20526		<1%	36	$8K
87075		<1%	2,338	$8K
86778		<1%	677	$8K
43762		<1%	72	$8K
29505		<1%	56	$8K
92550		<1%	125	$8K
80177		<1%	1,860	$8K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	12,043	$8K
96161		<1%	161	$8K
95028		<1%	28	$8K
99195		<1%	166	$8K
82960		<1%	2,765	$8K
86905		<1%	291	$7K
88311		<1%	645	$7K
80361		<1%	556	$7K
64413		<1%	14	$7K
29075		<1%	27	$7K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	17	$7K
80156		<1%	1,087	$7K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	15	$7K
77049		<1%	25	$7K
72220		<1%	669	$7K
99454		<1%	113	$7K
11730		<1%	39	$7K
J9250	Methotrexate sodium, 5 mg	<1%	2,487	$7K
J9046	Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg	<1%	470	$7K
85018		<1%	1,154	$7K
11100		<1%	12	$7K
97167		<1%	50	$7K
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	572	$7K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,347	$7K
96150		<1%	194	$7K
87209		<1%	864	$7K
80230		<1%	722	$7K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	2,173	$7K
86747		<1%	379	$7K
84238		<1%	208	$7K
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	229	$7K
80329		<1%	1,283	$7K
90714		<1%	278	$7K
31624		<1%	12	$7K
29065		<1%	28	$7K
92978		<1%	40	$6K
P9100	Pathogen(s) test for platelets	<1%	181	$6K
86160		<1%	710	$6K
20553		<1%	27	$6K
D2393	Resin-based composite - three surfaces, posterior, primary or permanent	<1%	115	$6K
J1644	Injection, heparin sodium, per 1000 units	<1%	8,308	$6K
L8600	Implantable breast prosthesis, silicone or equal	<1%	571	$6K
10160		<1%	24	$6K
97018		<1%	386	$6K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	6,423	$6K
82523		<1%	612	$6K
81403		<1%	63	$6K
77470		<1%	73	$6K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	512	$6K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	2,174	$6K
86920		<1%	66	$6K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	183	$6K
81050		<1%	2,129	$6K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,925	$6K
92201		<1%	80	$6K
99417	Prolong home eval add 15m	<1%	838	$6K
82077		<1%	7,003	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	21,100	$6K
86060		<1%	1,513	$6K
82575		<1%	1,076	$6K
0173A		<1%	144	$6K
93985		<1%	39	$6K
77332		<1%	18	$6K
82239		<1%	575	$6K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	8,429	$6K
G2074	Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)	<1%	354	$5K
99242		<1%	38	$5K
84145		<1%	1,220	$5K
77075		<1%	52	$5K
85347		<1%	693	$5K
83020		<1%	603	$5K
72193		<1%	24	$5K
86580		<1%	1,033	$5K
87324		<1%	1,343	$5K
80348		<1%	788	$5K
38222		<1%	13	$5K
0053A		<1%	128	$5K
88302		<1%	589	$5K
95012		<1%	140	$5K
64484		<1%	26	$5K
95800		<1%	85	$5K
77002		<1%	95	$5K
92553		<1%	64	$5K
94644		<1%	1,838	$5K
81370		<1%	103	$5K
82435		<1%	10,682	$5K
36000		<1%	136	$5K
91312		<1%	1,405	$5K
88143		<1%	202	$5K
81376		<1%	130	$5K
87350		<1%	678	$5K
A6223	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	127	$5K
83721		<1%	1,508	$5K
84112		<1%	261	$5K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	4,138	$5K
82232		<1%	546	$5K
85305		<1%	369	$4K
C2639	Brachytherapy source, non-stranded, iodine-125, per source	<1%	27	$4K
92520		<1%	54	$4K
85097		<1%	73	$4K
80195		<1%	634	$4K
87210		<1%	1,067	$4K
72083		<1%	113	$4K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	1,682	$4K
82172		<1%	481	$4K
90738		<1%	17	$4K
85597		<1%	289	$4K
93623		<1%	24	$4K
82104		<1%	466	$4K
86648		<1%	491	$4K
81241		<1%	97	$4K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	306	$4K
80365		<1%	644	$4K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	1,100	$4K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	536	$4K
74181		<1%	12	$4K
Q3014	Telehealth originating site facility fee	<1%	148	$4K
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	225	$4K
84075		<1%	1,485	$4K
91010		<1%	37	$4K
86701		<1%	552	$4K
81364		<1%	13	$4K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,081	$4K
99254		<1%	17	$4K
D1310		<1%	97	$4K
91313		<1%	438	$4K
85397		<1%	236	$4K
73660		<1%	610	$4K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	4,255	$4K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	4,498	$4K
99457		<1%	91	$4K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	12	$3K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	475	$3K
77001		<1%	12	$3K
92511		<1%	126	$3K
95910		<1%	51	$3K
86340		<1%	365	$3K
A6258	Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	243	$3K
92002		<1%	20	$3K
82040		<1%	1,997	$3K
99451		<1%	375	$3K
C1729	Catheter, drainage	<1%	80	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	9,828	$3K
86702		<1%	447	$3K
80299		<1%	368	$3K
73070		<1%	482	$3K
76604		<1%	87	$3K
D2331		<1%	55	$3K
L3670	Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf	<1%	1,180	$3K
82985		<1%	553	$3K
86336		<1%	515	$3K
A9567	Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries	<1%	167	$3K
C1731	Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)	<1%	12	$3K
99152		<1%	993	$3K
77012		<1%	25	$3K
97032		<1%	56	$3K
J1630	Injection, haloperidol, up to 5 mg	<1%	3,196	$3K
81240		<1%	66	$3K
80158		<1%	450	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	530	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	943	$3K
87101		<1%	377	$3K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	520	$3K
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	1,220	$3K
D9920		<1%	165	$3K
72202		<1%	108	$3K
86707		<1%	301	$3K
80143		<1%	2,754	$3K
93662		<1%	67	$3K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	2,583	$3K
11055		<1%	12	$3K
86300		<1%	221	$2K
92342		<1%	26	$2K
90658		<1%	186	$2K
87184		<1%	945	$2K
92588		<1%	81	$2K
84300		<1%	792	$2K
73223		<1%	13	$2K
82010		<1%	3,018	$2K
83030		<1%	1,063	$2K
J3489	Injection, zoledronic acid, 1 mg	<1%	105	$2K
0031A		<1%	61	$2K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	50	$2K
96040		<1%	25	$2K
83992		<1%	109	$2K
84460		<1%	812	$2K
82626		<1%	125	$2K
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	497	$2K
80179		<1%	2,597	$2K
85300		<1%	256	$2K
A6224	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	301	$2K
89320		<1%	214	$2K
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	728	$2K
87116		<1%	421	$2K
82955		<1%	313	$2K
64643		<1%	12	$2K
87102		<1%	455	$2K
93308		<1%	14	$2K
J1815	Injection, insulin, per 5 units	<1%	3,251	$2K
86353		<1%	14	$2K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	14	$2K
86703		<1%	151	$2K
64495		<1%	327	$2K
80356		<1%	200	$2K
76776		<1%	37	$2K
85303		<1%	178	$2K
D0240		<1%	172	$2K
99238	Hospital discharge day management, 30 minutes or less	<1%	12	$2K
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	<1%	26	$2K
95076		<1%	14	$2K
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	108	$2K
T1023	Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter	<1%	46	$2K
83935		<1%	415	$2K
94727		<1%	62	$2K
81002		<1%	3,131	$2K
74170		<1%	12	$2K
80358		<1%	256	$2K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,140	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	10,375	$2K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	44	$2K
J7999	Compounded drug, not otherwise classified	<1%	242	$2K
A5112	Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each	<1%	142	$2K
95873		<1%	70	$2K
90688		<1%	107	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,986	$2K
J2315	Injection, naltrexone, depot form, 1 mg	<1%	14	$2K
99239	Hospital discharge day management, more than 30 minutes	<1%	12	$2K
86308		<1%	1,016	$2K
96151		<1%	64	$2K
96130		<1%	32	$2K
93285		<1%	12	$2K
85460		<1%	183	$1K
81599		<1%	33	$1K
82656		<1%	222	$1K
99452		<1%	101	$1K
96136		<1%	41	$1K
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	145	$1K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	27	$1K
73120		<1%	53	$1K
85732		<1%	402	$1K
75571		<1%	39	$1K
99050		<1%	97	$1K
J7510	Prednisolone oral, per 5 mg	<1%	3,964	$1K
80175		<1%	171	$1K
86784		<1%	179	$1K
G0009	Administration of pneumococcal vaccine	<1%	170	$1K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	427	$1K
V5011	Fitting/orientation/checking of hearing aid	<1%	13	$1K
82952		<1%	900	$1K
D0270		<1%	210	$1K
87305		<1%	284	$1K
88368		<1%	12	$1K
73620		<1%	58	$1K
90672		<1%	120	$1K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	903	$1K
80320		<1%	3,253	$1K
72084		<1%	22	$1K
99153	Mod sedat endo service >5yrs	<1%	525	$1K
80162		<1%	212	$1K
S9441	Asthma education, non-physician provider, per session	<1%	462	$1K
D2335		<1%	12	$1K
80145		<1%	50	$1K
C9399	Unclassified drugs or biologicals	<1%	53	$1K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	855	$1K
85027		<1%	647	$1K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	576	$1K
76506		<1%	13	$984.00
87493		<1%	38	$955.33
80346		<1%	143	$949.97
93284		<1%	12	$945.70
98966		<1%	13	$927.69
C9113	Injection, pantoprazole sodium, per vial	<1%	601	$926.24
J3411	Injection, thiamine hcl, 100 mg	<1%	606	$911.30
V2787	Astigmatism correcting function of intraocular lens	<1%	32	$910.80
J2060	Injection, lorazepam, 2 mg	<1%	3,148	$907.12
76937		<1%	15	$899.48
81470		<1%	27	$895.72
90611		<1%	13	$887.01
74150		<1%	13	$871.00
D0145	Oral evaluation for a patient under three years of age	<1%	29	$870.00
0225U		<1%	158	$868.12
82360		<1%	219	$863.54
97535	Self-care/home management training, each 15 minutes	<1%	22	$834.96
86664		<1%	95	$830.91
84999		<1%	84	$827.15
84080		<1%	107	$814.87
90461		<1%	2,650	$810.15
71111		<1%	64	$806.95
A4615	Cannula, nasal	<1%	178	$797.90
73600		<1%	65	$796.96
86606		<1%	104	$795.66
90474		<1%	2,068	$794.70
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	1,577	$784.11
96131		<1%	23	$767.82
97750		<1%	27	$736.03
0054A		<1%	17	$732.39
G0117	Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist	<1%	68	$723.43
77081		<1%	27	$698.54
87533		<1%	19	$694.53
C1788	Port, indwelling (implantable)	<1%	12	$693.60
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	20,487	$692.67
70030		<1%	26	$671.93
99292		<1%	15	$660.00
86256		<1%	83	$641.02
J2598	Injection, vasopressin, 1 unit	<1%	50	$640.79
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	421	$613.79
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	14	$606.82
87015		<1%	326	$603.67
85007		<1%	649	$600.57
80353		<1%	71	$588.41
83718		<1%	338	$588.02
74175		<1%	12	$586.19
82140		<1%	205	$583.56
94799		<1%	989	$576.07
76820		<1%	18	$574.91
0013A		<1%	15	$572.47
85598		<1%	58	$571.29
83930		<1%	164	$567.71
73100		<1%	54	$559.44
93352		<1%	26	$555.94
72114		<1%	15	$553.24
99458		<1%	13	$525.88
93288		<1%	18	$518.36
87206		<1%	316	$517.22
96137		<1%	25	$517.13
90674		<1%	19	$515.82
G2025	Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only	<1%	60	$486.48
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	17,674	$475.85
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	<1%	112	$462.15
90660		<1%	32	$461.58
97124		<1%	21	$461.04
85520		<1%	45	$460.99
J3360	Injection, diazepam, up to 5 mg	<1%	232	$457.85
87046		<1%	228	$455.27
91315		<1%	148	$435.01
88141		<1%	13	$425.10
J1940	Injection, furosemide, up to 20 mg	<1%	788	$424.58
82810		<1%	283	$421.71
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	230	$419.41
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	87	$414.20
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	708	$399.15
93356		<1%	40	$393.75
82340		<1%	102	$384.66
80235		<1%	26	$341.68
88274		<1%	39	$334.01
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	308	$326.71
J8597	Antiemetic drug, oral, not otherwise specified	<1%	3,049	$318.32
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	226	$311.80
J2720	Injection, protamine sulfate, per 10 mg	<1%	182	$285.64
86337		<1%	28	$266.62
86663		<1%	26	$265.28
L1832	Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	12	$258.26
80185		<1%	61	$253.37
86316		<1%	26	$253.20
82747		<1%	16	$248.18
84450		<1%	100	$247.95
84202		<1%	41	$220.89
61782		<1%	29	$211.36
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	182	$197.51
J2305	Injection, nitroglycerin, 5 mg	<1%	327	$191.30
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	79	$190.68
A4333	Urinary catheter anchoring device, adhesive skin attachment, each	<1%	174	$189.08
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	12	$187.20
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	359	$176.63
J9260	Injection, methotrexate sodium, 50 mg	<1%	56	$171.14
83789		<1%	14	$170.28
82945		<1%	98	$148.35
80500		<1%	26	$146.92
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	14	$143.97
82962		<1%	852	$143.32
73551		<1%	39	$140.89
96373		<1%	12	$137.18
70250		<1%	13	$129.76
82705		<1%	42	$129.44
J2470	Injection, pantoprazole sodium, 40 mg	<1%	65	$128.86
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	13	$127.48
J0736	Injection, clindamycin phosphate, 300 mg	<1%	89	$109.93
Q0166	Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen	<1%	22	$94.98
S0028	Injection, famotidine, 20 mg	<1%	62	$90.33
OP250		<1%	76	$89.06
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	97	$88.27
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	96	$75.43
84482		<1%	13	$73.70
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	24	$71.92
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	139	$71.37
87045		<1%	14	$67.18
84157		<1%	38	$59.36
80183		<1%	13	$57.58
A6203	Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	164	$52.71
87450		<1%	97	$51.82
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	710	$49.73
96159		<1%	15	$46.24
84478		<1%	129	$40.24
87899		<1%	24	$37.32
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	20	$35.08
80362		<1%	13	$35.00
89060		<1%	12	$31.14
76010		<1%	14	$28.51
J1171	Injection, hydromorphone, 0.1 mg	<1%	117	$27.25
64636		<1%	72	$25.66
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	<1%	15	$21.90
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	122	$18.54
A6446	Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard	<1%	37	$15.81
82595		<1%	15	$14.25
85014		<1%	24	$12.41
A6454	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard	<1%	96	$10.75
A4340	Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each	<1%	13	$5.68
J1650	Injection, enoxaparin sodium, 10 mg	<1%	12	$5.28
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each	<1%	51	$4.94
A6403	Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	73	$4.84
91300		<1%	72	$3.23
J1071	Injection, testosterone cypionate, 1 mg	<1%	52	$1.39
A6252	Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	<1%	17	$1.30
A6253	Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	72	$0.65
A6445	Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard	<1%	19	$0.41
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	44	$0.39
Q0222	Injection, bebtelovimab, 175 mg	<1%	52	$0.22
J1836	Injection, metronidazole, 10 mg	<1%	27	$0.18
Q0239	Injection, bamlanivimab-xxxx, 700 mg	<1%	58	$0.17
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	306	$0.06
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	43	$0.02
D9999	Unspecified adjunctive procedure, by report	0%	264	$0.00
D6999		0%	142	$0.00
99429		0%	9,367	$0.00
D9215		0%	515	$0.00
D5899		0%	390	$0.00
D9630		0%	412	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	239	$0.00
99024		0%	27	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	14	$0.00
D1320		0%	15	$0.00
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	0%	13	$0.00
A9539	Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries	0%	15	$0.00
99080		0%	105,724	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	39	$0.00
99199	Unlisted special service, procedure or report	0%	407	$0.00
99499		0%	800	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	39	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBLYE, COLLEN (CHIEF FINANCIAL OFFICER)